The accumulation of Tc-labeled probes targeting saturable systems of the body is hindered by the presence of a large excess of unlabeled ligands needed to ensure high radiochemical yields in a short reaction time. To address the issue, we recently reported a novel concept of a metal-coordination-mediated synthesis of a bivalent Tc-labeled probe from a monovalent ligand using d-penicillamine (Pen) as a chelating molecule and c(RGDfK) as a model targeting device. The Pen-conjugated c(RGDfK) via a hexanoate linkage (Pen-Hx-c(RGDfK)) provided a bivalent [Tc]Tc-[(Pen-Hx-c(RGDfK)) that possessed much higher integrin αβ binding affinity than Pen-Hx-c(RGDfK) and visualized a murine tumor without purification. However, high radioactivity levels were observed in the abdominal regions, which necessitated improved pharmacokinetics of the probes for practical applications. In this study, a pharmacokinetic (PK) modifier was introduced to manipulate the pharmacokinetics of the Tc-Pen-based bivalent probe. The Hx linkage in Pen-Hx-c(RGDfK) was replaced with acetyl-d-serine-d-serine-glycine (Ac-ssG) or hexanoyl-d-serine-d-serine-d-serine (Hx-sss) to prepare Pen-Ac-ssG-c(RGDfK) or Pen-Hx-sss-c(RGDfK). Pen-Ac-ssG-c(RGDfK) impaired the complexation ability of Pen-Hx-c(RGDfK), and a monovalent Tc-labeled compound was generated at low ligand concentration. However, Pen-Hx-sss-c(RGDfK) provided the objective bivalent Tc-labeled probe in high radiochemical yields at a concentration similar to that of Pen-Hx-c(RGDfK). [Tc]Tc-[Pen-Hx-sss-c(RGDfK)] also possessed stability and integrin αβ binding affinity similar to those of [Tc]Tc-[Pen-Hx-c(RGDfK)]. As a result, [Tc]Tc-[Pen-Hx-sss-c(RGDfK)] exhibited tumor and abdominal radioactivity levels similar to and significantly lower than those of [Tc]Tc-[Pen-Hx-c(RGDfK)]. These findings indicate the incorporation of a tripeptide PK modifier to Pen-Hx-c(RGDfK) preserved the complexation ability and improved the pharmacokinetics of the resulting Tc-labeled bivalent probe without impairing the targeting ability. Thus, the [Pen-Hx-(PK modifier)-(targeting device)] would constitute a basic formulation for preparing the Tc-Pen-based bivalent probes for imaging saturable targets of the body.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.molpharmaceut.0c00070DOI Listing

Publication Analysis

Top Keywords

tc-labeled bivalent
8
bivalent probes
8
imaging saturable
8
saturable targets
8
high radiochemical
8
radiochemical yields
8
bivalent tc-labeled
8
tc-labeled probe
8
linkage pen-hx-crgdfk
8
integrin αβ
8

Similar Publications

Article Synopsis
  • Clinical trials for drugs targeting HER3 have struggled due to inefficacy, despite some cancer patients having higher levels of HER3 expression.
  • Novel drug delivery methods, such as affibody-based conjugates targeting HER3, are being explored to improve treatment outcomes.
  • The study demonstrated that a specific drug conjugate (Z-ABD-Z-mcDM1) showed promising tumor growth inhibition and extended survival in mice with pancreatic cancer compared to other treatments.*
View Article and Find Full Text PDF

Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes.

Sci Rep

September 2021

Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8501, Japan.

Hydroxamamide (Ham) is a thiol-free chelating agent that forms technetium-99m (Tc)-complexes with a metal-to-ligand ratio of 1:2 under moderate reaction conditions. Therefore, Ham-based chelating agents will produce Tc-labeled compounds with a bivalent targeting scaffold. For their universal usage, we developed a novel Ham-based bifunctional chelating agent, "Ham-Mal", with a maleimide group that can easily conjugate with a thiol group, for to preparing Tc-labeled bivalent ligand probes.

View Article and Find Full Text PDF

The accumulation of Tc-labeled probes targeting saturable systems of the body is hindered by the presence of a large excess of unlabeled ligands needed to ensure high radiochemical yields in a short reaction time. To address the issue, we recently reported a novel concept of a metal-coordination-mediated synthesis of a bivalent Tc-labeled probe from a monovalent ligand using d-penicillamine (Pen) as a chelating molecule and c(RGDfK) as a model targeting device. The Pen-conjugated c(RGDfK) via a hexanoate linkage (Pen-Hx-c(RGDfK)) provided a bivalent [Tc]Tc-[(Pen-Hx-c(RGDfK)) that possessed much higher integrin αβ binding affinity than Pen-Hx-c(RGDfK) and visualized a murine tumor without purification.

View Article and Find Full Text PDF

In the synthesis of technetium-99m (Tc) labeled target-specific ligands, the presence of a large excess of unlabeled ligands over Tc in the injectate hinders target accumulation of Tc-labeled ligands by competing for target molecules. To circumvent the problem, we recently developed a concept of the metal coordination-mediated multivalency, and proved the concept with a Tc-labeled trivalent compound [Tc(CO)(CN-RGD)]. In this study, D-penicillamine (Pen) was selected as a chelating molecule and a cyclic RGDfK peptide was conjugated to Pen via a hexanoic linkage (Pen-Ahx-c(RGDfK)).

View Article and Find Full Text PDF

Unlabelled: It was previously shown that the (99m)Tc-labeled hydrazinonicotinamide (HYNIC)-conjugated LTB4 antagonist MB81 visualized infectious foci in rabbits adequately and within a few hours after injection. Here, the bivalent HYNIC-conjugated LTB4 antagonist MB67 (analog of MB81) was fluorinated with (18)F via hydrazone formation and tested in vivo.

Methods: MB67 was [(18)F]-fluorinated via reaction of the [(18)F]-fluorinated intermediate p-[(18)F]-fluorobenzaldehyde ([(18)F]FB) and the HYNIC moiety of MB67 via hydrazone formation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!